Details
Description
The 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) was held August 24-28, 2019, in Philadelphia, PA. More information on the conference can be found here.
A variety of Sentinel-related work was featured, including presentations, posters, and more. These materials have been made available below.
Event Materials
Podium/Oral Presentations
- Utility of Prenatal Tests and Fertility Coding to Estimate Pregnancy Start in the Sentinel Distributed Database
- Characteristics of Febuxostat and Allopurinol Initiators and Utilization Patterns in Real-World Settings
- A General Propensity Score for Signal Detection using Tree-Based Scan Statistics
- Analysis of SGLT2 Inhibitor Use in Patients with Type-1 Diabetes Mellitus and Rates of Diabetic Ketoacidosis
- 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Kawasaki Disease
Posters
- Dolutegravir Use Among Women of Child-Bearing Potential and During Early Pregnancy
- Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illnesses in Young Children
- Phosphodiesterase-5 Inhibitor Use Among Pregnant Women and Women of Child-bearing Age in the United States
- Confounding Variable Capture in Large Healthcare Administrative Claims Databases: A Trend Analysis in Sentinel Data System
- Characteristics of NOAC Users Aged Less Than 65 Years in the Sentinel System
- Evidence of Residual Confounding in Healthcare Database Studies of Oseltamivir and Influenza Complications
- Characteristics and Treatment Status of Those with Influenza-Like Illness: Implications for Effectiveness Studies and Surveillance
- Utilization of Prescription Anti-Obesity Drugs in the U.S. Food and Drug Administration's (FDA) Sentinel System, 2008-2017
- Duration of Follow-up of Chronic Condition Cohorts in the Sentinel System
- Identification of Ordinal Endpoints Indicating Influenza Complications: A Feasibility Analysis Relevant to the Study of Medical Countermeasures
- Complementary Use of US FDA's Adverse Event Reporting System and Sentinel Distributed Database to Characterize Direct Oral Anticoagulants Associated Cutaneous Small Vessel Vasculitis
- Biosimilar Use in the United States: A Sentinel Analysis of Filgrastim and Infliximab
- Exposure to N-nitrosodimethylamine (NDMA)/N-nitrosodiethylamine (NDEA)-contaminated Angiotensin-II Receptor Blockers Products in the United States
Symposia